" "What we're fighting is the greed. The greed and the additional maneuvering that is being exercised after you've already recouped what you've invested. There is no control, no regulation," Ayalew Tefferi, a hematologist at Mayo Clinic and the first signator on the new editorial, said in an interview.
The pharmaceutical industry counters that its medicines provide great value to patients and the health-care system, and that high prices are needed to fund future research and development.
"Too often the focus has been solely on the price of a medicine, and largely ignored the value these medicines are providing," said Robert Zirkelbach, a spokesman for the Pharmaceutical Research and Manufacturers of America. "We've made tremendous strides in the fight against cancer—death rates are down, survival rates are up, and quality of life continues to improve." "